Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**HERC2 pseudogene 4 (HERC2P4)** is classified as a processed pseudogene, meaning it is a non-coding DNA sequence that resembles the functional HERC2 gene but does not encode a functional protein. Pseudogenes like HERC2P4 are typically considered genomic remnants resulting from gene duplication or retrotransposition events. There is currently no evidence supporting a direct biological function, disease association, or druggability for HERC2P4 itself. Its parent gene, HERC2, encodes a large E3 ubiquitin ligase implicated in DNA repair and several other critical cellular processes, but these functions do not extend to the pseudogene[2][6]. No specific biological processes, disease associations, or drug interactions are described for HERC2P4 in current literature, nor is there evidence that it serves as a biomarker or therapeutic target. If an actual target function or disease relevance for HERC2P4 is demonstrated in future research, the above information should be updated. Currently, "HERC2P4" is not considered a standard therapeutic target and is not incorrectly spelled, but is often incorrectly presumed to be a functional gene or therapeutic receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HERC2 pseudogene 4 (HERC2P4).